🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:

#ASCO25: City of Hope’s Sumanta K. Pal, MD, FASCO breaks down IMmotion010 — a phase 3 #clinicaltrial aiming to uncover the mechanisms behind therapy resistance in patients with localized #kidneycancer.

Inviting my fellow #oncologists attending #ASCO25 to join us for this year's City of Hope reception, starting at 7:30 pm at the #Chicago The Ritz-Carlton Ballroom. A great opportunity to meet our amazing team! Loretta Erhunmwunsee, MD, FACS Hope Rugo Stacy W. Gray Thanh Dellinger Krupal Patel Dr. Ravi Salgia

🌟Great presentation by Chadi Hage Chehade at #ASCO25!! Utilization and timing of NGS in pts w/ 5 most common cancers in the US👉Many pts either don’t receive NGS or have the first NGS very late 👇ASCO OncoAlert Neeraj Agarwal, MD, FASCO Umang Swami Flatiron Health UroToday.com

🏔️ A standing ovation at #ASCO25 for Dr. Christopher Booth and the CHALLENGE (CO.21) trial. A 3-year structured exercise program post-chemo in stage II/III colon cancer: ✅ Improved OS (HR 0.63, p=0.022) ✅ 1 life saved for every 14 patients 💬 “Exercise is no longer just a QOL

🥗 Powerful diet-focused study at #ASCO25 presented by Sara Khosrowjerdi Char, MD from CALGB/SWOG 80702: 🔹 Proinflammatory diet linked to worse OS in stage III colon cancer 🔹 Best outcomes in patients with high physical activity and anti-inflammatory diet 🔹 NSAIDs didn’t alter the

These City of Hope fellows do #ASCO25! So thankful to be co-fellows with this amazing group of people who are inspiring and fun and for the opportunity to attend conferences like these 🤩 Lawrence Liu Peter Zang Natasha Sumanta K. Pal, MD, FASCO Tanya Dorff Neal S. Chawla Jing Ji Matthew Mei

🎖️ASCO TECAG lounge starts with "Establishing Work-Life Balance and Boundaries" session with Nazli Dizman Sumanta K. Pal, MD, FASCO Edward S. Kim, MD, MBA, FACP, FASCO & Dionisia Quiroga, DO, PhD ⏰6/2 8:00 AM - 8:45 AM📷ASCO #ASCO25 #MedEd ASCO OncMedEdCoP IMG Oncologists

🌄Bright and early at the ASCO TECAG Lounge! ASCO #ASCO25 💫Please join me, Sumanta K. Pal, MD, FASCO Edward S. Kim, MD, MBA, FACP, FASCO Dionisia Quiroga, DO, PhD as we discuss strategies for physician well-being, practical tips on work-life balance and how to set boundaries! ⏰6/2 8.00-8.45 AM Dr. Ravi Salgia Toni Choueiri, MD Alexis LeVee, MD

The OncoAlert🚨 RoundUp DAY THREE #ASCO25 👉REGISTER HERE OncoAlert360.com OR buff.ly/p0O1gZ8 FOR A MORE COMPLETE VIEW of the TOP of DAY 3 of the congress JOIN THE NEWSLETTER Discussing: ✅CHALLENGE: Excercise & adj Chemo #ColonCancer ✅MATTEHHORN: in

Starting soon. Come join us in S100bc this morning at 8 AM.

Day 4 of #ASCO25 Highlights with the one and only Dr. McGregor 🕛8:45-9:00 📍Hall D1 Poster session starting at 9:00AM in hall A with some great work in #RCC! Stay tuned!

Hot topic! Marc Machaalani fantastic IM applicant this upcoming cycle presents data on KIM-1 in JR101 #ASCO25 OncoAlert

Excellent conversations on early-onset cancers in our session today at #ASCO2025. Registrants can check out the recording in the link below. Our audience raised so many important issues — make sure early-onset & AYA definitions are more inclusive...(1/3) meetings.asco.org/2025-asco-annu…

Grateful for the opportunity to present our CLONEVO investigator-initiated trial (IIT) in bladder cancer at ASCO #ASCO2025. Here are some lessons I learned along the way: Investigator-initiated trials (IITs) are essential. IITs are clinical trials independently designed and led

Finally had a chance to listen to the discussion EVERYONE in the GU community is talking about via ASCO Virtual Meeting. One of the most thoughtful & eloquent discussions I have ever seen by Jacqueline T. Brown, MD Winship Cancer Institute of Emory University, summarizing excellent presentations from Michiel van der Heijden

Read our review on gut #microbiome as a target for #cancer #immunotherapy at Nature Reviews Drug Discovery

🗣️Prostate Oral Abstract #ASCO25 👉Abst5004: Dr Alicia Morgans, MD, MPH presenting #HRQoL w/ darolutamide on #ARANOTE 📈HRQoL assessed by: - FACT-P: Funct Assessmt of Cancer Therapy–Prostate - BPI-SF: Brief Pain Inventory–Short Form

Congrats Alicia Morgans, MD, MPH for the outstanding talk ASCO #ASCO25 👉favorable health-related QOL reported by the pts in ph3 ARANOTE trial treated with darolutamide in mHSPC #prostatecancer 👇OncoAlert UroToday.com PCF Science @fredsaad

Leaving Chicago & #ASCO25 with full heart. Reminded of our common purpose to #curecancer and make a difference for our patients. Thanks ASCO for a wonderful data, networking, & inspiration filled weekend!